Alternative methods, dose of tradition

Oversight: As head of an NIH office, Dr. Stephen Straus is determined to shine the cold light of science on medical self-care.

April 18, 2000|By Gary Dorsey | Gary Dorsey,SUN STAFF

Unlike most Americans, Dr. Stephen Straus does not spend a cent on alternative medicine.

Twenty-three years as a scientist in the labs at the National Institutes of Health have left him skeptical of mysterious palliatives, fabulous marketing claims and the power of suggestion.

He is so conventional that he includes his one regular daily ritual -- downing a single multivitamin and an aspirin -- among the wild assortment of "alternative" treatments ascribed to by legions of believers.

For the first time in its controversial history, the alternative medicine headquarters at NIH has one of its own at the helm, a confident scientist and a New Yorker who questions commercial markets, unexamined toxic properties, flimsy clinical studies and the vulnerability of an American public smitten by a bug to accept even the most peculiar trends in self-care.

Managing controversy and conflict is likely to be part of the job.

But for a 53-year-old physician whose greatest impact has been on discrete public health issues such as herpes and chronic fatigue, the opportunity to influence one of the most contentious debates in contemporary medicine -- the validity of alternative medicines -- seemed too good to pass up. The job places him among the vanguard, and he appears pleased to be there.

"It's an extraordinary opportunity," Straus said recently. "Right now there is this huge knowledge vacuum.

"And in the absence of information, people are led by anecdote and rumor and TV and articles they read from magazines at the supermarket. It's driven by the marketplace and not by science. We have to change that."

In his first few months on the job, modest portents of what will likely become a routine diet of provocative news have touched his doorstep.

In March, The Journal of the American Medical Association published a study questioning the ability of magnets to reduce back pain. At Duke University recently, researchers at a national symposium evaluated herbal remedies, warning of dangers of unregulated herbs and bemoaning markets flooded with "junk products." Last month, a University of Maryland team reported false labeling claims in a variety of glucosamine products.

When he heard news of an NIH study in February pointing out the potentially harmful effects of mixing St. John's wort with AIDS medication, his response was impassioned.

"St. John's wort sold $6 billion worldwide last year," he said. "There is not a prescription drug on the planet that has sold $6 billion in a year. I don't think there's one that sold $3 billion.

"This is a big business, and people are investing a lot of money capturing shares of that market. Now I want to see an investment in research capturing the data."

Forceful declarations such as this might seem odd from a virologist who, until now, conducted science cautiously alongside geneticists and pathologists. For years, he spent his days tracking cellular diversions of a latent herpes virus or directing microscopic detective work on the elusive Epstein-Barr virus.

With a vision of rigorous science, increasing internal support for his center and a budget steadily expanding to $68 million, Straus seems prepared to be the voice of reason in an often maligned but enormously popular field of medicine.

"Over time the skeptics and advocates will see we can be trusted," he said. "If something works, I'll be out there in front of the microphone saying, `This is the first definitive proof.'

"And if it doesn't work, I'm going to be at the microphone saying, `We have definitive proof.' You can't satisfy everybody that way. But the American public will benefit."

Straus is not a wild advocate, but the conservative physician has won over many alternative practitioners, the iconoclasts fervently endorsing herbs and meditation and acupuncture whom he will scrutinize and likely challenge as the first major studies of alternative therapies are completed over the next few years.

"Dr. Straus may not be the cheerleader of alternative medicine today, but he may be tomorrow," said Marilyn Schlitz, a parapsychology researcher at the Institute of Noetic Sciences in Sausalito, Calif., who serves on the center's advisory council.

"He's willing to embrace some initiatives that are remarkably bold."

Since his appointment in October, the virologist has impressed people such as Schlitz, whose interests range from shamanistic mysticism to telepathic healing. Larry Dossey, best-selling author of New Age works such as "Recovering the Soul" and "Reinventing Medicine," cheers Straus' emergence as a sign that NIH is willing to take alternative medicine seriously.

"From what I can tell, Dr. Straus is open and eager and highly qualified. He won't let the cynics shut them down," said Dossey, a member of an advisory board that helped shape an agenda for the original Office of Alternative Medicine in 1992.

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.